The subject may sound strange but it is true that one encounters such instances in day to day business deals. I was part of one of the out licensing deals of my Client A, a biotech company that was interested…
Biosimilars remain a hot topic with news yesterday that Indian generic drug giant Cipla, who only last week was praised by former president Bill Clinton, has launched the first Rheumatoid Arthritis biosimilar of Pfizer and Amgen?s blockbuster Enbrel. With its successes in producing generic chemical…
Biosimilars is the topic of the day as news broke of Indian Agila Biotech?s joint venture with US Pfenex Inc to produce Biosimilar products. Under the agreement Agila Biotech will hold 51% equity of the joint venture that will take advantage of…
There has been considerable amount of debate on what discount rates should be used in each and every phases of a biotech project. Should you use the cost of capital of the company while evaluating projects? The answer is clearly…
India?s generic drug manufacturers have received a large amount of negative press in the last few weeks and it is at times like this that it is important to remind ourselves of the key role these companies play in combating…
Shasun Pharmaceuticals and Debiopharm Group have entered into a licensing agreement to manufacture and commercialise the acetylcholinesterase inhibitor “Huperzine-A” (HupA) that has been shown to improve cognitive performance in patients that suffer from Alzheimer?s Disease (AD). According to the deal, Shasun Pharmaceuticals…
The World Health Organisation has approved India?s vaccine regulatory system that will allow India?s vaccine producers to easily export vaccines out of the country. The regulatory system passed the WHO?s international standards for efficacy indicators for a functional vaccine regulatory system based…
Last week I covered India?s landmark ruling against granting Novartis patent protection for its Leukaemia and gastrointestinal cancer drug “Glivec”. The ruling received both domestic and international criticism that drove India?s trade and industry minister, Anand Sharma, to defend India?s judiciary…
Decision Tree Analysis (DTA) is one of the tools that is used to account for uncertainty and encapsulates the later decisions by the management. It is useful for analyzing sequential investment decisions at discrete points of time. In DTA, the…
With the recent rejection of Novartis? patent hitting the headlines India?s generic drug market is back in the news, this time Mumbai-based Glenmark Pharmaceuticals Ltd. is the target and Merck (MSD) is looking to sue over patent-infringement. Glenmark recently announced two anti-diabetic…